CLINICAL_TRIALS ClinicalTrials.gov record update

Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of GSK Biologicals' Hepatitis B Vaccine Engerix™-B Kinder (SKF103860) Challenge Dose in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa (SB217744) During Infancy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02052661
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:54.767820+00:00
Published At: 2015-08-27T00:00:00+00:00
Record Updated At: 2018-06-06
Results Posted At: 2015-08-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis B"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-06-06"
protocolSection.identificationModule.nctId: "NCT02052661"
protocolSection.identificationModule.officialTitle: "Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of GSK Biologicals\u0027 Hepatitis B Vaccine Engerix\u2122-B Kinder (SKF103860) Challenge Dose in Adolescents Vaccinated With Four Doses of Infanrix\u2122 Hexa (SB217744) During Infancy"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2015-08-27"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.